Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 80
  • Journal CiteScore: 29.12
  • Journal Impact Factor: 19.45*
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

- (2008) Volume 9, Issue 1

Laparoscopic Distal Pancreatectomy in Non-Malignant Pancreatic Tumors

Riccardo Casadei, Claudio Ricci, Nicola Zanini, Nicola Marrano, Raffaele Pezzilli, Francesco Minni

Department of Surgery, S.Orsola-Malpighi Hospital, University of Bologna. Bologna, Italy

*Corresponding Author:
Riccardo Casadei
Dipartimento di Chirurgia Policlinico S.Orsola-Malpighi
Via Massarenti, 9
40138 Bologna Italy
Phone: +39-051.341.541
Fax: +39-051.341.483
E-mail: riccardo.casadei@aosp.bo.it

Received September 9th, 2007 - Accepted November 14th, 2007

Visit for more related articles at Journal of the Pancreas

Keywords

Laparoscopy; Neoplasms; Pancreatectomy

Dear Sir,

It is known that laparoscopy is not usually accepted as the treatment of choice for pancreatic tumors [1, 2, 3, 4, 5]. Even if laparoscopic pancreatectomy is rarely performed and is considered an elite surgical approach because of technical difficulties, long operative time and long learning curve, in recent years, laparoscopic distal pancreatectomy has become an increasingly used technique in the surgical treatment of several pancreatic diseases, including nonmalignant tumors [6, 7, 8].

From May 2004 to August 2007, data from 10 consecutive patients who underwent laparoscopic distal pancreatectomy were entered into our surgical database. There were 2 males and 8 females with a mean age of 59.0±16.2 (SD) years. Five of them (50%) were affected by non-malignant cystic tumors (3 serous cystadenomas, 2 mucinous cystic tumors) and 5 (50%) had non-malignant endocrine tumors (4 insulinomas and 1 nonfunctioning tumor). Two patients (20%) had an American Society of Anesthesiologists physical status (ASA score) equal to 3 or 4, and 8 (80%) had ASA score equal to 1 or 2.

According to the accepted criteria [9], distal pancreatectomy is defined as the resection of the pancreas reaching the left side of the superior mesenteric vein. Laparoscopic distal pancreatectomy was performed as follows:

1) after general anesthesia, the patient was kept supine, is positioned in a 30-45 degree right lateral decubitus with the patient’s hip at the break in the table; the surgeon, the first assistant and the scrub nurse stand to the right of the patient. Pneumoperitoneum was achieved using a Hasson trocar and three other ports were placed. We used a 10 mm 30-degree telescope for visualization.

2) The gastrocolic ligament was opened allowing access to the pancreas. Laparoscopic ultrasonography was used at this stage to delineate the tumor and identify its relationship to the splenic vessels. After mobilization of the distal pancreas from the retroperitoneum and splenic vessels (spleenpreserving distal pancreatectomy), the pancreas was divided at the neck using an Endo-GIA® instrument (Ethicon Endo- Surgery, Cincinnati, OH, USA). It is to be stressed that, when performing a spleenpreserving distal pancreatectomy we always preserved the splenic vessels. In en bloc distal pancreatectomy with splenectomy, the splenic vessels were clipped, separately. The specimen was removed using an endo-bag through an incision in the left upper quadrant. A closed system suction drain was placed at the pancreatic bed.

Several parameters, regarding the characteristics of the tumor, intraoperative procedure and postoperative course, were analyzed and summarized in Table 1. During laparoscopic distal pancreatectomy, a splenectomy is usually performed; a spleenpreserving procedure is possible when the tumor is small and it is not localized near the splenic hilus. In our series, only two patients underwent a spleen-preserving procedure. The tumor size of patients who underwent laparoscopic surgery is usually small, even if cystic tumors may be bigger than neuroendocrine tumors. Operating time was longer at the beginning of the learning curve (first 5 cases: 240±59 min, mean±SD) than it was at the end (last five cases: 198±42 min). the postoperative results were very good with no mortality and few complications (1 pancreatic fistula, 1 hemorrhage, 1 pulmonary infection). Re-operation was necessary due to a postoperative hemorrhage from the splenic vessels.

table

In conclusion, our data confirmed the safety and feasibility of laparoscopic distal pancreatectomy in the treatment of nonmalignant pancreatic tumors. Laparoscopic surgery in high volume centers could be performed with an acceptable operating time, without important blood loss and could allow good postoperative results. Finally, we would point out that one of the difficulties in randomized and/or controlled studies on this topic is mainly due to the fact that patients in the laparotomic population may have significantly larger tumors than patients laparoscopically treated; the laparotomic and the laparoscopic groups may not have comparable clinical characteristics, mainly due to different study periods [10].

Conflict of interest

The authors have no potential conflicts of interest

References